A second dramatic rise in seroprevalence rates of SARS-CoV-2 antibodies among adult healthy blood donors in Jordan; have we achieved herd immunity? Preprint
GHDx Entry last modified on: May 12, 2022
Blood tests
Dataset Records for Blood tests
Displaying 1 - 50 of 1424
Guinea Malaria Indicator Survey 2021
République de Guinée Enquête sur les Indicateurs du Paludisme et de l’Anémie en Guinée (EIPAG) 2021
Survey:
Cross-sectional - GPS coordinates (GIS) - Household - Individual - Nationally representative - Subnationally representative - Urban-rural representative
Andhra Pradesh: '59% found to have Covid antibodies in sero-survey'
Survey:
Epi surveillance
Presence of antibodies to SARS-CoV-2 in Sweden, 26 April - 9 May 2021
Förekomsten av antikroppar mot SARS-CoV-2 i Sverige, 26 april – 9 maj 2021
Survey:
Epi surveillance
[Seroprevalence to SARS-CoV-2 among the population of the Belgorod Region amid the COVID-19 epidemic]
GHDx Entry last modified on: Mar 14, 2022
Madagascar Demographic and Health Survey 2021
Enquête Démographique et de Santé (EDSMD-V)
Survey:
GPS coordinates (GIS) - Household - Individual - Interview - Nationally representative - Verbal autopsy
Jharkhand: 45% of population in 10 districts positive before 2nd wave: Sero survey
Survey:
Epi surveillance
Portugal National Serological Survey COVID-19 (2nd phase) 2021
Inquérito Serológico Nacional COVID-19 (2.ª fase) (INS COVID-19)
Survey:
Individual
Brazil - Sergipe Evolution of the Prevalence of SARS-CoV-2 Infection 2021, Third Phase
Evolução da Prevalência de Infecção por SARS-CoV-2 em Sergipe. Terceira Fase: 18 de fevereiro a 30 de março de 2021.
Survey:
Epi surveillance
Netherlands - Coronavirus antibodies in an average of 18.6% of the donors
Antistoffen coronavirus bij gemiddeld 18,6% van de donors
Hidden fraction of Polish population immune to SARS-CoV-2 in May 2021. Preprint
GHDx Entry last modified on: Mar 14, 2022
Brazil - São Paulo Household Survey to Estimate the Seroprevalence of SARS-CoV-2 Infection, Phase 5 (SoroEpi MSP)
Avaliação da prevalência da infecção pelo vírus SARS-CoV-2 em habitantes do município de São Paulo: Resultados Parciais da Fase 5
Prevalence of anti-SARS-CoV-2 antibodies among blood donors in Northern Cape, KwaZulu-Natal, Eastern Cape, and Free State provinces of South Africa in January 2021. Preprint
GHDx Entry last modified on: May 12, 2022
Canada - Ontario Daily Epidemiological Summary of COVID-19 2021
Epidemiologic Summary COVID-19 in Ontario
Serological prevalence of SARS-CoV-2 antibody among children and young age (between age 2-17 years) group in India: An interim result from a large multi-centric population-based seroepidemiological study. Preprint
GHDx Entry last modified on: Apr 8, 2022
Seroprevalence of SARS-CoV-2 infection in the Colombo Municipality region, Sri Lanka. Preprint
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 seroprevalence in Chattogram, Bangladesh before a National Lockdown, March-April 2021. Preprint
GHDx Entry last modified on: Mar 14, 2022
Anti-spike protein receptor-binding domain IgG levels after COVID-19 infection or vaccination against SARS-CoV-2 in a seroprevalence study. Preprint
GHDx Entry last modified on: May 12, 2022
Seropositivity highest in Madhya Pradesh, lowest in Kerala, finds ICMR's national sero-survey
Survey:
Epi surveillance
COVID Symptoms, Seroprevalence, and Mortality During the First Wave of SARS-CoV-2 in Canada. Preprint.
GHDx Entry last modified on: Nov 5, 2021
SARS-CoV-2 antibody prevalence in Sierra Leone, March 2021: a cross-sectional, nationally representative, age-stratified serosurvey. Preprint
GHDx Entry last modified on: Mar 14, 2022
COVID-19 antibody seroprevalence in Duhok, Kurdistan Region, Iraq: A population-based study. Preprint
GHDx Entry last modified on: Mar 14, 2022
Socioeconomic position and SARS-CoV-2 infections: seroepidemiological findings from a German nationwide dynamic cohort. Preprint
GHDx Entry last modified on: Mar 14, 2022
Prevalence of SARS-CoV-2 antibodies in Denmark 2020: results from nationwide, population-based sero-epidemiological surveys. Preprint
GHDx Entry last modified on: May 12, 2022
Senegal Malaria Indicator Survey 2020-2021
Enquête des Indicateurs du Paludisme au Sénégal 2020-2021 (EIPS 2020-2021)
Survey:
Cross-sectional - Household - Individual - Interview - Nationally representative - Subnationally representative - Urban-rural representative
SARS-CoV-2 infection and transmission in school settings during the second wave in Berlin, Germany: a cross-sectional study. Preprint
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of antibodies against SARS-CoV-2 virus in the adult Norwegian population, winter 2020/2021: pre-vaccination period. Preprint
GHDx Entry last modified on: May 12, 2022
High Seroprevalence of SARS-CoV-2 Eight Months After Introduction in Nairobi, Kenya. Preprint
GHDx Entry last modified on: May 12, 2022
Kenya Malaria Indicator Survey 2020
Survey:
Cross-sectional - GPS coordinates (GIS) - Household - Individual - Interview - Nationally representative - Subnationally representative - Urban-rural representative
Serum-epidemiological Survey of SARS-CoV-2, Cities of Xai-Xai and Chókwè (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Xai-Xai e Chókwè (InCOVID 2020) - Resultados Preliminares -
South Africa COVID-19 Special Public Health Surveillance Bulletin, Volume 18 Supplementary Issue 9, 12 March 2021
COVID-19 Special Public Health Surveillance Bulletin Volume 18 (Issue 9: 12 Mar 2021)
Epi surveillance:
Cross-sectional - Individual
Puerto Rico Community Assessment for Response to Public Health Emergencies (CASPER) 2020
Evaluación Comunitaria para la Respuesta a Emergencias de Salud Pública (CASPER)
Survey:
Epi surveillance
33.98% of Tripura has COVID-19 antibody in them, shows sero survey
Survey:
Epi surveillance
Brazil - Sao Paulo Household Survey to Estimate the Seroprevalence of SARS-CoV-2 Infection, Phase 4 (SoroEpi MSP)
Avaliação da prevalência da infecção pelo vírus SARS-CoV-2 em habitantes do município de São Paulo: Resultados Parciais da Fase 4
India - Haryana Covid-19 Sero Survey Round 2, October 2020
Sero-prevalence of Anti-SARS-CoV-2 IgG antibodies in Haryana, India: A Population based Cross-Sectional Study (2nd Round)
Survey:
Cross-sectional - Epi surveillance - Urban-rural representative
Brazil - Maranhão Prevalence of SARS-CoV-2 Virus Infection Survey 2020 Phase II
Prevalência de infecção pelo vírus SARS-CoV-2 no Maranhão, segunda fase
Survey:
Individual - Interview
4.7% of the Austrian population had antibodies against SARS-CoV -2 in mid / late October
GHDx Entry last modified on: May 12, 2022
Nepal National Sero-Prevalence Survey for COVID-19 2020 Round 1
ENHANCED SURVEILLANCE ON SERO-PREVALENCE OF SARS-COV-2 IN GENERAL POPULATION
Seroprevalence of SARS-CoV-2 Infection Among Occupational Groups from Bucaramanga Metropolitan Area, Colombia. Preprint
GHDx Entry last modified on: Oct 5, 2022
Kolkata: One in Four People Have Covid Antibodies
GHDx Entry last modified on: May 12, 2022
C''garh: 5.5 pc people have COVID-19 antibodies, says sero survey
Survey:
Cross-sectional - Epi surveillance - Individual
Canada COVID-19 Seroprevalence in Ontario: September 3 to October 30, 2020
GHDx Entry last modified on: May 12, 2022
Serum-epidemiological Survey of SARS-CoV-2, City of Lichinga (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Lichinga (InCOVID 2020) - Resultados Preliminares -
SARS-CoV-2 infections in kindergartens and associated households at the start of the second wave in Berlin, Germany – a cross sectional study. Preprint
GHDx Entry last modified on: Mar 14, 2022
Serum-epidemiological Survey of SARS-CoV-2, City of Beira (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Beira (InCOVID 2020) - Resultados Preliminares -
Serum-epidemiological Survey of SARS-CoV-2, City of Tete (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Tete (InCOVID 2020) - Resultados Preliminares -
Serum-epidemiological Survey of SARS-CoV-2, City of Quelimane (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Quelimane (InCOVID 2020) - Resultados Preliminares -
Sero-pravelence of SARS CoV-2 IgM and IgG Antibodies Amongst Blood Donors in Nigeria. Preprint
Scientific literature:
Epi surveillance
Canada COVID-19 Seroprevalence in Ontario: August 1 to August 31, 2020
COVID-19 Seroprevalence in Ontario: August 1 to August 31, 2020
Subscribe